Balyasny Asset Management »

Ngm Biopharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $573k 361k 1.59
2022-12-31 $78k 16k 5.02

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Ngm Biopharmaceuticals

Column Group
BlackRock
Vanguard Group
StepStone
Euclidean Capital
Geode Capital Management
Trium Capital
ADAR1 Capital Management
Two Sigma Advisers
Northern Trust
Balyasny Asset Management
Federated Investors
Citadel Advisors
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Ngm Biopharmaceuticals